Sunday, October 4, 2015

Improvements in the synthesis and understanding of the iodo-bridged intermediate en route to the Pt(IV) prodrug satraplatin #chempaperaday 233

Satraplatin is a Pt(IV) prodrug and the route to satraplatin is still in debate. In this article the authors propose a iodo-bridged intermediate and an improved synthesis to this intermediate. Really nice work and characterization methods.



http://www.sciencedirect.com/science/article/pii/S0020169314005477

1 comment:

  1. atraplatin, also known as JM216, is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. Satraplatin

    ReplyDelete